Free. Unsubscribe any time.
Blueprint Medicines Corp (BPMC)
Blueprint Medicines Corp filed 14 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 35 transactions and 56,180 shares. None carries the SEC's AFF10B5ONE flag; all 14 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2025-05-29, came 8 days after the one before it (2025-05-21) and reports 4 transactions against 3 in the filing before it.
- The sales it reports total 5,000 shares, 2,726 more than the 2,274 in the filing before it.
- Its 14 filings on file run from 2025-01-15 to 2025-05-29, and state no plan adoption date.
Trades in Blueprint Medicines Corp 35
- Albers Jeffrey W. — 2025-01-13 · S · 5,000 shares
- Hurley Ariel — 2025-01-13 · S · 2,250 shares
- Albers Jeffrey W. — 2025-01-21 · S · 7,561 shares
- Albers Jeffrey W. — 2025-01-21 · S · 7,400 shares
- Albers Jeffrey W. — 2025-01-21 · S · 200 shares
- Haviland Kate — 2025-01-21 · S · 1,446 shares
- Rossi Christina — 2025-01-21 · S · 529 shares
- Rossi Christina — 2025-01-21 · S · 816 shares
- Rossi Christina — 2025-01-21 · S · 808 shares
- Rossi Christina — 2025-01-21 · S · 121 shares
- Rossi Christina — 2025-02-20 · S · 2,274 shares
- Hurley Ariel — 2025-03-03 · S · 775 shares
Adoption dates in Blueprint Medicines Corp 0
Results prints in Blueprint Medicines Corp 0
Trades before a print in Blueprint Medicines Corp 0
Interval to Blueprint Medicines Corp’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 35no later print
Sources: SEC EDGAR full-text search and the SEC submissions API.